[144] Surgery Partners, Inc. SEC Filing

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) submitted a Form 144 notifying a proposed sale of 3,145 common shares through UBS Financial Services with an approximate market value of 65,269.9, and an approximate sale date of 10/09/2025 on NASDAQ. The securities were acquired on 10/09/2025 via equity compensation and paid by equity option exercise.

The filing also lists multiple prior open-market sales by the named person, Wayne DeVeydt, across dates from 08/21/2025 to 10/08/2025, including several large single-day blocks (up to 150,000 shares). The notice includes the required attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Full regulatory disclosure of the proposed sale via Form 144, including acquisition method (equity option exercise)
• Broker identified for the sale: UBS Financial Services, providing execution transparency

Negative

• Multiple insider sales reported from 08/21/2025 to 10/08/2025, including a block of 150,000 shares, which represent material insider liquidity over a short period
• Proposed sale scheduled for 10/09/2025 could add incremental selling supply on NASDAQ

Insights

Insider Transactions Analyst

TL;DR: Multiple recent insider sales and a proposed sale from exercised equity make insider liquidity visible to investors.

The filing shows a proposed sale of 3,145 common shares arising from an equity option exercise and executed via UBS Financial Services on 10/09/2025. The seller also conducted numerous open-market sales between 08/21/2025 and 10/08/2025, including single transactions as large as 150,000 shares.

These items increase publicly visible insider liquidity and help investors track potential supply pressure on the stock; monitor short-term trading volumes and price action around the listed sale dates over the next few trading sessions for any immediate market impact.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3145	65269.9	128209410	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	10/09/2025	equity compensation	Surgery Partners, Inc.			3145	10/09/2025	equity option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/26/2025	25000	572717
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/27/2025	11865	271756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/02/2025	25000	562150
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/03/2025	25000	560251
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/04/2025	25000	562756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/05/2025	25000	563682
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/08/2025	2014	45207
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/11/2025	100000	2200741
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/12/2025	28700	628929
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/16/2025	25000	541518
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/17/2025	85785	1873875
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/18/2025	150000	3294425
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/19/2025	10613	234547
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/22/2025	50000	1092666
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	commoon	09/23/2025	25000	550386
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/26/2025	5627	123794
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/29/2025	18134	399822
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	10/08/2025	25000	513186

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Surgery Partners (SGRY) disclose?

The Form 144 discloses a proposed sale of 3,145 common shares acquired via equity compensation and an equity option exercise, with an approximate market value of 65,269.9 and an approximate sale date of 10/09/2025 on NASDAQ.

Who is the seller named in the Form 144 and related recent sales?

The recent sales listed name Wayne DeVeydt as the seller for multiple open-market transactions between 08/21/2025 and 10/08/2025.

How many shares have been sold by the named person in the recent three months?

The filing lists numerous sales across the period, including single-day blocks up to 150,000 shares; the transactions are itemized by date and gross proceeds in the filing.

How were the 3,145 shares to be sold acquired?

The 3,145 shares were acquired on 10/09/2025 through equity compensation and the payment was an equity option exercise.

Which broker will execute the proposed sale?

The proposed sale is to be executed through UBS Financial Services Inc at the address shown in the filing.